Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome

October 11, 2018 -- Trevena, Inc. (NASDAQ: TRVN), today announced the outcome of the meeting of the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to review and discuss oliceridine. At the...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news